Medical Device Innovation Consortium (MDIC), through its public-private partnership, aims to advance regulatory science in the medical device industry. MDIC will coordinate the development of methods, tools, and resources used in managing the total product life cycle of a medical device to improve patient access to cutting-edge medical technology.
Members of MDIC share a vision of providing U.S. patients with timely access to high-quality, safe and effective medical devices.
Our board includes the director of CDRH, the director of Coverage and Analysis at CMS, C-level executives representing patient organizations, non-profits, and industry.
MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science.
We are a nonprofit 501(c)3 organization that operates in partnership with the FDA to improve the medical technology environment.
Participation in MDIC is open to representatives of organizations that are substantially involved in medical and/or medical device:
That are involved in the promotion of public health; or that have expertise in regulatory science.
MDIC works on science, not policy.
Our work improves patient access and safety while reducing costs to the healthcare system. We work on what is important to all stakeholders. We are helping to re-engineer the tools for innovation and regulatory assessments to address the unsustainable cost trajectory of medical technology innovation